Literature DB >> 1459525

Treatment of locoregional recurrence after intentional curative resection of pancreatic cancer.

M B Menke-Pluymers1, J H Klinkenbijl, M Tjioe, J Jeekel.   

Abstract

In order to analyze the results of treatment of patients with locoregional recurrence after intentional curative resection of pancreatic cancer, a retrospective study was performed. During the period 1978-1988, 108 patients underwent an intentional curative resection fo the pancreas. In 34 patients locoregional recurrence occurred, all within a period of three years (cumulative recurrence rate 56%). Sixty-eight percent of the patients presented with upper abdominal pain, and 62% with weight loss. Survival was significantly better (p = 0.02) in the group of 18 patients without distant metastases (1-year survival 22%) than in the 16 patients with distant metastases (1-year survival 0%). Five patients without proven distant metastases were treated by resection or chemotherapy. The mean survival was 33 months (range 6-74) in the treated group, and 4 months (0.4-7 months) in the untreated group, p = 0.002. In this retrospective study the longest survival was seen after radical resection of locoregional tumor recurrence. We therefore recommend that patients with locoregional recurrence without distant metastases after intentional curative resection of pancreatic cancer be treated.

Entities:  

Mesh:

Year:  1992        PMID: 1459525

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  7 in total

1.  Analysis of liver metastasis after resection for pancreatic ductal adenocarcinoma.

Authors:  Kwang Yeol Paik; Seong Ho Choi; Jin Seok Heo; Dong Wook Choi
Journal:  World J Gastrointest Oncol       Date:  2012-05-15

2.  Surgery for recurrent pancreatic ductal adenocarcinoma.

Authors:  Jörg Kleeff; Carolin Reiser; Ulf Hinz; Jeannine Bachmann; Jürgen Debus; Dirk Jaeger; Helmut Friess; Markus W Büchler
Journal:  Ann Surg       Date:  2007-04       Impact factor: 12.969

Review 3.  Adjuvant chemotherapy in pancreatic cancer.

Authors:  S R Bramhall; J P Neoptolemos
Journal:  Int J Pancreatol       Date:  1997-02

Review 4.  Resection of Recurrent Pancreatic Cancer: Who Can Benefit?

Authors:  Henrik Nienhüser; Markus W Büchler; Martin Schneider
Journal:  Visc Med       Date:  2021-11-11

5.  Tumor relapse after pancreatic cancer resection is detected earlier by 18-FDG PET than by CT.

Authors:  Cosimo Sperti; Claudio Pasquali; Sergio Bissoli; Franca Chierichetti; Guido Liessi; Sergio Pedrazzoli
Journal:  J Gastrointest Surg       Date:  2009-09-24       Impact factor: 3.452

6.  Surgery for recurrence of periampullary malignancies.

Authors:  Thomas Zacharias; Elie Oussoultzoglou; Daniel Jaeck; Patrick Pessaux; Philippe Bachellier
Journal:  J Gastrointest Surg       Date:  2008-12-03       Impact factor: 3.452

7.  Resection of isolated local and metastatic recurrence in periampullary adenocarcinoma.

Authors:  Brian A Boone; Herbert J Zeh; Brady K Mock; Paul J Johnson; Igor Dvorchik; Ken Lee; A James Moser; David L Bartlett; J Wallis Marsh
Journal:  HPB (Oxford)       Date:  2013-04-22       Impact factor: 3.647

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.